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Abstract:
Background: Persistent antigenic stimulation due to repeated exposure to nickel may lead to chronic inflammation resulting in 
allergic contact dermatitis (ACD). 
Objectives: This study was performed to assess nickel induced immune activation among patients sensitized against nickel.
Patients and Methods: A total of  35 patients (29 females and 6 males; mean age 36±9 years) with nickel contact dermatitis and 
20 patch test negative healthy individuals  (14 females and 6 males; mean age 29±7 years) were included in this study. Peripheral 
blood of  patients and controls was incubated with nickel sulfate for 24 hours. Immune activation was assessed by CD69 up-reg-
ulation on T lymphocyte sub-sets by flow cytometry. 
Results: Base line expression of  CD69 on CD8+ lymphocytes was higher among patients compared to controls 
(4.1±1.3%vs2.8±1.1%;p<0.009). There was no difference in proportions of  CD±CD69+ cells between patients and controls 
(3.2±0.9%vs2.3±0.8%). Exposure to nickel induced expression of  CD69 on a significantly higher proportion of  CD4+ lympho-
cytes (22.1±6.2%) of  the ACD patients compared to controls (2.8±2.5%;p<0.0001). Similarly nickel induced CD69 expression 
on a higher proportion of  CD8+ lymphocytes (18.2±5.3%) from ACD patients compared to the controls (1.9±1.8%;p<0.0006).
Conclusion: CD69 molecule appears to be an important regulator of  immune response in nickel contact dermatitis.   
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Contact sensitization due to nickel is common and about 
15% population globally is believed to have allergic con-
tact dermatitis (ACD) due nickel.1 Inflammation associ-
ated with nickel induced ACD is driven by delayed type 
hypersensitivity reaction mediated by T cell responses.2 
Experimental studies have shown that nickel ions serving 
as haptens are processed and transported to the draining 
lymph nodes by dendritic cells where these are present-
ed to T lymphocytes eventually leading to priming of  T 
lymphocytes.3 Persistent exposure to nickel results in ac-
tivation and proliferation of  the primed T cells in situ4 
generating a complex inflammatory milieu clinically man-
ifesting as ACD.5 Evidence suggests that CD8+ cells per-
form as effector cells whereas CD4+ are endowed with 
down-regulatory functions6 by limiting the development 
of  effector CD8+ cells in ACD.7 Massive infiltration of  
IL-17, IL-22 and interferon gamma (IFN-g) producing 
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CD4+ cells at the site of  nickel challenged skin indicates 
important role of  CD4+ T cells as effector cells in ACD8 
most likely by CD69 mediated regulation of  Th17 cells.9
 
CD69 is an early cell activation marker expressed on 
stimulated cells and is a reliable predictor of  cell prolif-
eration.10 Monocytes, platelets and Langerhans cells nor-
mally express CD39 whereas the resting lymphocytes in 
the peripheral blood do not express this molecule.11-13 
CD69 is rapidly induced on human T and B lymphocytes, 
natural killer cells, neutrophils and eosinophils following 
activation.11,12,14 More over type 1 interferons have been 
shown to up-regulate the expression of  CD69.15 Fol-
lowing in vitro stimulation CD69 can be detected on the 
surface of  lymphocytes after two hours, peaks between 
18 to 24 hours and gradually decreases after 24 hours.16 
Rapid induction of  CD69 is due to the presence of  this 
molecule in the cytoplasm and does not require RNA or 
protein synthesis.14 It is primarily due to this property that 
CD69 is widely used as an early marker for cell activation. 
This in vitro study was performed to assess the expres-
sion of  CD69 on T cell sub-sets following exposure to 




This study was performed at King Khalid University 
Hospital between January 2012 and June 2014 among pa-
tients with clinical suspicion of  ACD. Out of  the 55 pa-
tients testing positive to nickel as single allergen 35 con-
sented to participate in the study. This group of  patients 
included 29 female and 6 males (mean age 36+9 years). 
All patients were suffering from clinically active disease 
and among them 23 had lesions on hands, 7 on feet and 
5 had lesions on ears.  A control group comprising of  
twenty otherwise normal individuals with negative patch 
test reactivity was also included in the study. This group 
of  healthy individuals included 14 females and 6 males 
with the mean age of  29±7 years. Patients with either 
negative patch test reactivity or reacting to allergens other 
than nickel or with positive reactions against nickel along 
with other allergens were not included in the study. None 
of  the patients were receiving oral corticosteroids at the 
time of  sample collection or at least one month prior to 
inclusion in the study. Patients with chronic inflammatory 
disorders or with the history of  transient viral or bacte-
rial infection one month before were also excluded from 




Patch test was performed using TRUE Test (Mekos Lab-
oratories AS, Denmark) comprising of  a panel of  24 al-
lergens/allergen mixes. The test panels of  12 allergens 
each were applied on the upper back of  the patient on the 
healthy skin free of  acne, scars, dermatitis or any other 
skin condition that might interfere with the interpretation 
of  the results. Patients were instructed to wear the patch-
es for 48 hours, avoid strenuous exercise and contact with 
water. Interpretation of  the results was performed initial-
ly after 48 hours followed by a second evaluation 72-96 
hours after the application. Patients were instructed to 
report back to the clinic in case of  delayed reactions. The 
interpretation of  the results was performed by Allergolo-
gist in accordance with the recommendations of  the In-
ternational Contact Dermatitis Research Group and the 
North American Contact Dermatitis Group. The inten-
sity of  the skin reactivity was graded as +, ++ and +++.
 
 
Nickel sulfate challenge assay
After obtaining the informed consent of  each patient and 
control 5ml of  venous blood was withdrawn from an-
ticubital fossa in a vacutainer containing anti-coagulant. 
Assessment of  CD69 expression was performed at the 
time of  sample collection as the baseline CD69 expres-
sion and after nickel sulfate challenge. The optimal con-
centration of  nickel sulfate was determined by checker 
board titration assay. Prior experiments had demonstrat-
ed that the whole blood incubation with nickel sulfate at 
a concentration of  100 µM/ml for 24 hours was adequate 
for maximum expression of  CD69 marker. To a 200 ml 
aliquot of  heparinized whole blood in 5ml test tube both 
from the patients and controls equal volume of  nickel 
sulfate at a concentration of  100 µM/ml was added. For 
the negative control tube 200 μl of  10% RPMI-1640 was 
dispensed in 200 ml of  heparinized whole blood.  The 
cultures were incubated in 5% CO2  at 37°C and 95% hu-
midity for 24 hours in CO2 incubator (Thermo Scientific, 
Heraeus, HERA cell 150). After the incubation the cells 
were labeled with relevant monoclonal antibodies for 
flow cytometry.
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Cell labeling and flowcytometry
To the contents of  each 5ml test tube a cocktail of  anti-
bodies comprising of  20 μl of  each fluorochromes conju-
gated mouse anti-human CD69, anti-CD4, anti-CD8 and 
anti-CD3 monoclonal antibody (Becton Dickinson Im-
munocytometry system, San Joes Calif) was added. Each 
tube was vortexed gently and incubated for 15 minutes in 
dark at room temperature. After the incubation 2ml of  
1xFACS lysing solution (B.D Biosciences, San Jose, CA 
59131 USA) was dispensed into each tube and incubated 
for 10 minutes in dark at room temperature. After the 
incubation 2 ml of  wash buffer was added (Optimized 
PBS for cell preparation and cell washing B.D Bioscienc-
es, Cat No. 349524) and each tube was centrifuged at 500 
x g for 5 minutes at room temperature. The supernatant 
was decanted and the cell pallet was finally re-suspend-
ed in 500 μl of  1% paraformaldehyde (B.D Biosciences 
pharmingen 10975 Torreyana Rd. San Diego, CA 92121 
) in calcium and magnesium free PBS (Dulbecco’s Phos-
phate-Buffered Saline PAA Laboratories GmbH PAA-
Strasse 1 Austria) prior to flow cytometric analysis. Flow 
cytometry was performed using FACSCalibur (Becton 
Dickinson, San Jose, CA, USA). BD CaliBRITE beads 
were used for setting photomultiplier tube voltages, flu-
orescence compensation and for checking instrument 
sensitivity for lymphocyte surface markers. In acquisition 
mode a total of  10000 events were acquired and the anal-
ysis was performed using Cell Quest software (Becton 
Dickinson). The negative thresholds were set using iso-
type-control-labeled cells from both patients and normal 
controls. Data were collected as percentage of  each cell 
type expressing the relevant marker.  
 
Statistical analysis
Data analysis was performed using Statistical Package 
For Social Sciences (SPSS) version 20 computer software. 
Categorical data were summarized as number and per-
centages and numeric data were summarized as mean and 
standard deviation. Comparison between the groups was 




Figure 1 shows comparison of  the baseline expression of  
CD69 on CD4+ T lymphocytes and CD8+ T lymphocytes 
among the patients with ACD and the control group. The 
mean percentage of  CD4+ T lymphocytes expressing 
CD69 molecule among the control group was 2.3±0.8% 
and among the patients was 3.2±0.9%. Similarly the mean 
percentages of  CD69 expressing CD8+ T lymphocytes 
among the controls and patients were 2.8±1.1% and 
4.1±1.3% respectively. 
 
Fig 1. Base line expression of CD69 on CD4+ and CD8+ T  
lymphocyte subsets of nickel induced allergic contact  
dermatitis and controls. 
                   
                       *=p<0.009 
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Whereas the percentages of  CD69/CD4+ were no differ-
ent between the patients and the controls the proportion 
of  CD69/CD8+ among ACD patients were significant-
ly higher than the controls (p<0.009). Nickel challenge 
among 24 controls failed to induce CD69 on CD4+ and 
CD8+ T lymphocytes (Fig. 2). 
Nickel challenge for 24 hours however was associated 
with significant up-regulation of  CD69 expression on 
both CD4+ and CD8+ T lymphocytes. Figure 3 shows 
data for nickel induced CD69 expression on both the 
T cell sub-sets. After 24 hours of  incubation of  whole 
blood from patients with positive patch test for nickel the 
percentage of  CD69/CD4+ cells (22.1±6.2%) was signifi-
cantly higher (p<0.0001) than the controls (2.8±2.5%). 
Similarly the percentage of  CD69/CD8+ T lympho-
cyte following 24 hours incubation with nickel sulfate 




Fig. 2. CD69 expression on CD4+ and CD8+ T lymphocyte subsets 
of controls following 24 hour incubation with either RPMI or 
nickel sulfate (100 μΜ/ml). 
 
  
Fig. 3. Comparison of CD69 induction on CD4+ and CD8+ T 
lymphocyte subsets from patients with nickel induced contact  
dermatitis and controls following 24 hour incubation 
with nickel sulfate. (100 μΜ/ml). 
                   *=p<0.0001 
                   **=p<0.0006 
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Discussion
Base line expression of  CD69 on CD8+ T lymphocytes 
was higher in patch test positive patients with ACD. En-
hanced expression of  CD69 on a variety of  cells has been 
associated with allergic disorders. Increased number of  
CD69+ eosinophils has been reported in the bronchoalve-
olar lavage fluid of  patients with allergic asthma following 
segmental allergen provocation.17 Presence of  higher pro-
portion of  circulating CD69+ eosinophils among infants 
with atopic dermatitis has not only been linked with high 
levels of  total IgE but has also been associated with ac-
tive allergic inflammation.18 Elevated numbers of  CD69+ 
lymphocytes found in the sputa of  patients with asthma 
are believed to be due to enhanced antigenic challenge.19 
Similarly exposure of  peripheral blood mononuclear cells 
to allergens has been shown to increase the surface ex-
pression of  CD69 on natural killer cells.20 Induction of  
CD69 expression on a wide variety of  hematopoietic cells 
as a result of  allergenic stimulation could possibly be a 
function of  allergen specific clones releasing high levels 
of  IFN-g particularly in nickel allergy.21 Collectively these 
data suggest that increased expression of  CD69 in aller-
gic disorders may serve as marker of  disease activity.
 
Nickel was able to induce CD69 molecule on both CD4+ 
and CD8+ T cells after 24 hours in the present study.  An 
study investigating the effect of  monosodium urateon-
trinitrochlorobenzene-induced contact hypersensitivity 
responses in mice has revealed increased expression of  
CD69 on both CD4+ and CD8+ T lymphocytes indicat-
ing activation of  both cell types.22 Interaction between 
activated T cell subsets particularly in contact dermatitis 
appears to be complex. Hapten-stimulated CD8+ effector 
cells mainly produce IFN-g promoting an inflammatory 
milieu whereas CD4+ lymphocytes on the other hand ex-
ert a negative regulatory effect by producing IL-4, IL-5 
and IL-10.23 Because of  the cytokine profile it may be 
inferred that ACD is CD8+ lymphocyte induced disor-
der regulated by CD4+ lymphocytes. However in some 
mouse models CD4+ lymphocytes have also been shown 
to behave as effector cells.24 A recent study has demon-
strated nickel dependent IL-9 release from the peripheral 
blood mononuclear cells of  nickel sensitized individuals. 
IL-9 by promoting IL-4 production may also perform a 
regulating cytokine in nickel induced dermatitis.25 In ad-
dition naïve CD4 T lymphocytes from CD69 deficient 
animals fail to differentiate in Foxp3+ and induction of  
CD69 promotes generation of  Foxp3+ regulatory cell 
population.26 The pathogenesis of  contact dermatitis in 
general and nickel induced ACD in particular remains ob-
scure and could possibly be a mixed Th1/Th2 response. 
 
The ability of  nickel sulfate to consistently induce CD69 
on CD4+ and CD8+ T lymphocytes offers a useful oppor-
tunity for development of  in vitro test for detection of  
nickel sensitization as an alternate test for in vivo, cum-
bersome and time consuming patch test. In addition the 
existence of  a strong correlation between the induction 
of  CD69 and cell proliferation10 may obviate the need 
for using potentially hazardous radioactive materials in 
lymphoproliferation assays. Moreover flowcytomeric as-
sessment of  CD69 up-regulation on CD4+ T lymphocytes 
in vitro has been successfully applied in detection of  sen-
sitization due to Mycobacterim TB antigen.27 Metal ions re-
leased from orthopedic implants have been shown to in-
duce CD69 molecule and activate CD3+ lymphocytes that 
can be detected by flow cytometry with a relative ease.28 
In vitro stimulation of  CD4+ T lymphocytes with drugs 
and induction of  CD69 surface expression has been suc-
cessfully evaluated in discriminating individuals with drug 
allergy from those with no drug allergy.29 As opposed to 
other metals nickel sulfate has non-specific stimulatory 
properties that may interfere with in vitro testing for nick-
el sensitization.30 The inherent stimulatory properties of  
nickel probably did not interfere with the results in the 
present study as the expression of  CD69 on control cells 
whether challenged with nickel sulfate or RPIM was no 
different. Development of  in vitro testing for nickel and 
other contact allergens based on induction of  CD69 may 
be a useful in avoiding intense local inflammatory reac-
tions often associated with patch test. The observations 
of  the present study require validation in immune-com-
promised individuals particularly HIV infected patients 
where anergic delayed type hypersensitivity skin reactions 
are frequently observed that tend to normalize following 
successful anti-retroviral treatment.31  
 
Conclusion 
Peripheral blood cells from patients with ACD sensitized 
against nickel responded to in vitro nickel challenge by 
enhanced expression of  CD69 activation marker. Al-
though antigenic stimulation and cytokine release may 
have induced CD69 on T cell sub-sets the possibility of  
CD69 up-regulation on nickel specific T cell clones could 
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not be excluded. Sensitization due to nickel is common 
and development of  in vitro test based on nickel induced 
CD69 up-regulation may be a useful alternative to the 
gold standard patch test. 
 
Declaration
Authors declare no conflict of  interest. 
 
References
1.    Mahler V, Geier J, Schnuch A. Current trends in patch 
testing – new data from the German Contact Dermatitis 
Research Group (DKG) and the Information Network 
of  Departments of  Dermatology (IVDK). J Dtsch Derma-
tol Ges. 2014; 12: 583– 92. doi: 10.1111/ddg.12371.
2.    Martin SF, Esser PR, Weber FC, Jakob T, Freudenberg 
MA, Schmidt M, et al. Mechanisms of  chemical-induced 
innate immunity in allergic contact dermatitis. Allergy. 2011; 
66: 1152–63. doi: 10.1111/j.1398-9995.2011.02652.x. 
PubMed.  
3.    Kaplan DH, Igyarto BZ, Gaspari AA. Early immune 
events in the induction of  allergic contact dermatitis. Nat 
Rev Immunol. 2012; 12: 114–24.  doi: 10.1038/nri3150. 
PubMed.
4.    Natsuaki Y, Egawa G, Nakamizo S, Ono S, Hanakawa 
S, Okada T et al. Perivascular leukocyte clusters are essen-
tial for efficient activation of  effector T cells in the skin. 
Nat Immunol. 2014; 15: 1064– 9.   doi: 10.1038/ni.2992. 
PubMed.
5.    Kerstan A, Leverkus M, Trautmann A. Effector path-
ways during eczematous dermatitis: where inflammation 
meets cell death. Exp Dermatol. 2009; 18: 893–9. doi: 
10.1111/j.1600-0625.2009.00919.x. PubMed.
6. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, 
Nicolas JF. The role of  CD4+ and CD8+ T cells in con-
tact hypersensitivity and allergic contact dermatitis. Eur J 
Dermatol. 2004;14(3):131-8. PubMed. 
7.    Gautam S, Matriano J, Chikkala M, Edinger M, Tubbs 
R. L3T4 (CD4) T cells that mediated contact sensitivity 
to trinitroclorobenzene express I-A determinants. Cell. 
Immunol. 1991;135:27.
8.    Dyring-Andersen B, Skov L, Løvendorf  MB, Bzorek 
M, Søndergaard K, Lauritsen JP, et al. CD4(+) T cells 
producing interleukin (IL)-17, IL-22 and interferon-γ are 
major effector T cells in nickel allergy. Contact Dermatitis. 
2013;68(6):339-47. PubMed. doi: 10.1111/cod.12043.
9.    Martín P, Sánchez-Madrid F. CD69: an unexpect-
ed regulator of  TH17 cell-driven inflammatory respons-
es. Sci Signal. 2011;22;4(165):pe14. doi: 10.1126/scisig-
nal.2001825. PubMed.
10. Caruso A, Licenziati S, Corulli M, Canaris AD, De 
Francesco MA, Fiorentini S, et al. Flow cytometric analysis 
of  activation markers on stimulated T cells and their cor-
relation with cell proliferation. Cytometry. 1997;27(1):71-6. 
PubMed. 
11. Testi R, Phillips JH, Lanier LL. Constitutive ex-
pression of  A phosphorylated activation antigen (Leu 
23) by CD3(bright)human thymocytes. J Immunol. 
1988;141(8):.2557–2563.
12. Sanchez-Mateos P, Cebrian M, Acevedo A, Lopez-Bo-
tet M, Landazuri MO, Sanchez-Madrid F. Expression of  
agp33/27,000MWactivation inducer molecule (AIM) on 
humanlymphoid tissues. Induction of  cell proliferation 
on thymocytes and B lymphocytes by anti-AIM antibod-
ies. Immunology. 1989;68(1):72–79.
13. Testi R, Pulcinelli F, Frati L, Gazzaniga PP, Santoni 
A. CD69 is expressed on platelets and mediates plate-
let activation and aggregation. J Exp Med. 1990; 172 (3): 
701–707.
14. Risso A, Smilovich D, Capra MC Baldissarro I, Yan G, 
Bargellesi A, et al. CD69 in resting and activated T lym-
phocytes: its association with a GTP binding protein and 
biochemical requirements for its expression. J Immunol. 
1991;146(12):4105–4114.
15. Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke 
U. Type I interferons directly regulate lymphocyte recir-
culation and cause transient blood lymphopenia. Blood. 
2006;108(10): 3253–3261.
16. Testi R, Ambrosio DD, deMaria R, Santoni A. 
TheCD69 receptor: a multipurpose cell-surface trigger for 
hematopoietic cells. Immunology Today. 1994;15(10):479–
483.
17. Julius P, Luttmann W, Knoechel B, Kroegel C, Mat-
thys H, Virchow JC Jr. CD69 surface expression on 
human lung eosinophils after segmental allergenprov-
ocation. Eur Respir J. 1999; 13:1253–1259. PubMed. 
[PubMed:10445598]
18. Toma T, Mizuno K, Okamoto H, Kanegane C, Ohta 
K, Ikawa Y et al. Expansion of  activated eosinophils in 
infants with severe atopic dermatitis. Pediatr Int. 2005; 
47:32–38. PubMed.
19. Lourenco O, Mafalda Fonseca A, Taborda-Barata 
L. T cells in sputum of  asthmatic patients are activated 
African Health Sciences Vol 19 Issue 1, March, 2019 1465
independently of  diseaseseverity or control. Allergol Im-
munopathol (Madr). 2009; 37:285–292.  doi: 10.1016/j.al-
ler.2009.05.004.
20. Werfel T, Boeker M, Kapp A. Rapid expression of  the 
CD69 antigen on T cells and natural killer cells upon an-
tigenic stimulation of  peripheral blood mononuclear cell 
suspensions. Allergy. 1997; 52:465– 469. PubMed.
21. Kapsenberg ML, Wierenga EA, Stiekema FE, Tiggel-
man AM, Bos JD. Th1 lymphokine production profiles 
of  nickel-specific CD4+ T lymphocyte clones from nickel 
contact allergic and non allergic individuals. J Invest Der-
matol. 1992; 98: 59–63. PubMed.
22. Liu L, Inoue H, Nakayama H, Kanno R, Kanno 
M. The endogenous danger signal uric Acid augments 
contact hypersensitivity responses in mice. Pathobiology. 
2007;74(3):177-85. PubMed. 
23. Xu H, DiIulio NA, Fairchild RL. T cell populations 
primedby hapten sensitization in contact sensitivity are 
distinguished bypolarized patterns of  cytokine produc-
tion: interferon gammaproducing(Tc1) effector CD8+ T 
cells and interleukin (Il) 4/Il-10-producing (Th2) negative 
regulatory CD4+ T cells. J Exp Med. 1996; 183: 1001–12. 
PubMed.
24. Honda T, Egawa G, Grabbe S, Kabashima K. Update 
of  immune events in the murine contact hypersensitiv-
ity model: toward the understanding of  allergic contact 
dermatitis. J Invest Dermatol. 2013; 133: 303–15. PubMed. 
doi: 10.1038/jid.2012.284. 
25. Liu J, Harberts E, Tammaro A, Girardi N, Filler RB, 
Fishelevich R. IL-9 regulates allergen specific Th1 re-
sponses in allergic contact dermatitis. J Invest Dermatol. 
2014; 134: 1903–11. PubMed.  doi: 10.1038/jid.2014.61.
26. Radulovic K, Manta C, Rossini V Holzmann K, 
Kestler HA, Wegenka UM, et al. CD69 regulates type I 
IFN-induced tolerogenic signals to mucosal CD4 T cells 
that attenuate their colitogenic potential,” J Immunol. 
2012;188(4):2001–2013. PubMed.  doi: 10.4049/jimmu-
nol.1100765. 
27. Avgustin B, Kotnik V, Skoberne M, Malovrh T, Sk-
ralov-nik-Stern A, Tercelj M. CD69 expression on CD4+ 
T lymphocytes after in vitro stimulation with tuberculin 
is an indicator of  immune sensitization against Myco-
bacterium tuberculosis antigens. Clin Diagn Lab Immunol. 
2005;12: 101-106.
28. Granchi D, Ciapetti G, Savarino l, Stea S, Filippini 
F, Sudanese A, et al. Expression of  the CD69 activation 
antigen on lymphocytes of  patients with hip prosthesis. 
Biomaterials. 2000; 21: 2059-2065 PubMed.
29. Beeler A, Zaccaria L, Kawabata T, Gerber BO, Pichler 
WJ. CD69 upregulation on T cells as an in vitro mark-
er for delayed-type drug hypersensitivity. Allergy. 2008; 
63:181-188 PubMed.
30. Cederbrant K, Anderson C, Andersson T, Marcus-
sonstahl M, Hultman P. Cytokine production, lympho-
cyteproliferation and t-cell receptor Vbeta expression 
in primary peripheral blood mononuclear cell cultures 
fromnickel-allergic individuals. Int Arch Allergy Immunol. 
2003; 132: 373-379.
31. Minidis NM, Mesner O, Agan BK, Okulicz JF. De-
layed type hypersensitivity (DTH) test anergy does not 
impact CD4 reconstitution or normalization of  DTH 
responses during antiretroviral therapy. J Int AIDS Soc. 
2014 Feb 4;17:18799. doi: 10.7448/IAS.17.1.18799.
African Health Sciences Vol 19 Issue 1, March, 20191466
